# Lenvima

NDC: 62856-704
Generic name: Lenvatinib
Labeler / Manufacturer: Eisai Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20180815

FDA application: NDA206947

## Active ingredients

- LENVATINIB: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62856-704"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62856-704
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e